CONTROL OF SCHISTOSOMIASIS-MANSONI IN A LOW TRANSMISSION AREA

被引:0
|
作者
DIAS, LCD
JUNIOR, OM
GLASSER, CM
KANAMURA, HY
HOTTA, LK
机构
[1] UNIV FED UBERLANDIA,UBERLANDIA,BRAZIL
[2] UNIV SAO PAULO,FAC CIENCIAS FARMACEUT,SAO PAULO,BRAZIL
来源
关键词
SCHISTOSOMIASIS; SCHISTOSOMA-MANSONI; CONTROL;
D O I
暂无
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The schistosomiasis is transmitted by Biomphalaria tenagophila in our study area (Pedro de Toledo, Sao Paulo, Brazil). From 1980 to 1990 epidemiological surveys in a population of 4, 000 inhabitants, has shown that: prevalences by Kato-Katz (KKT), immunofluorescence (FT) and intradermal (IDT) techniques were 22.8%, 55.5% and 51.8%, respectively; intensity of infection was low, 58.5 eggs per gram of faeces (epg); there were no symptomatic cases; prevalences were higher in mates, children and rural zone; index of potential contamination was 57.5% in the age group 5 to 20 years; 213 of patients were autochthonous; cases were no-randomly aggregated; transmission was focal and only 0.4% of snails were infected; water contacts through recreation showed the most important odds ratio; knowledge, attitudes and pratices were satisfatory. From the epidemiological findings a control programme was carried out: yearly faeces exams, chemotherapy, molluscocide, health education and sanitation. Thus, the prevalence decreased sharply to 3.3% and intensity of infection to 30.3 epg; the incidence rates ranged between 0.4% and 2.5% annualy; the sanitation became better and the youngsters were the main target in prophylaxis. To improve control, immunodiagnosis has to be conducted and the involvement of the population should be increase. However, we cannot forget that re-infection, therapeutic failure, etc, could play a major role in the maintenance this residual prevalence.
引用
收藏
页码:233 / 239
页数:7
相关论文
共 50 条
  • [31] CHEMOTACTIC FACTOR FOR GRANULOCYTES IN SCHISTOSOMIASIS-MANSONI
    DABES, TMP
    GARCIA, AA
    COLLEY, DG
    RAMALHOPINTO, FJ
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1985, 18 (5-6) : A616 - A616
  • [32] IMMUNE-RESPONSE IN SCHISTOSOMIASIS-MANSONI
    CESARI, IM
    INTERCIENCIA, 1990, 15 (02) : 74 - 74
  • [33] MASS TREATMENT OF SCHISTOSOMIASIS-MANSONI WITH HYCANTHONE
    POLDERMAN, AM
    MANSHANDE, JP
    TROPICAL AND GEOGRAPHICAL MEDICINE, 1980, 32 (04): : 367 - 367
  • [34] ANTIBODY ISOTYPES IN HUMAN SCHISTOSOMIASIS-MANSONI
    JASSIM, A
    HASSAN, K
    CATTY, D
    PARASITE IMMUNOLOGY, 1987, 9 (06) : 627 - 650
  • [35] AN OPERATIVE APPROACH TO THE TREATMENT OF SCHISTOSOMIASIS-MANSONI INFECTIONS
    BRANDT, JL
    SCIENCE, 1947, 105 (2722) : 239 - 240
  • [36] MICROENCAPSULATION OF ASTIBAN ACID FOR THE TREATMENT OF SCHISTOSOMIASIS-MANSONI
    GOPALRATNAM, PC
    MASON, NS
    SPARKS, RE
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 1984, 10 : 213 - 220
  • [37] MICROENCAPSULATION OF ASTIBAN ACID FOR TREATMENT OF SCHISTOSOMIASIS-MANSONI
    GOPALRATNAM, PC
    MASON, NS
    SPARKS, RE
    ARTIFICIAL ORGANS, 1984, 8 (01) : 111 - 111
  • [38] CANDIDATE EPITOPES FOR VACCINATION AGAINST SCHISTOSOMIASIS-MANSONI
    HARN, DA
    OLIGINO, L
    KO, A
    STEIN, LD
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 151 - 151
  • [39] BRAZILIAN CONTRIBUTIONS TO EPIDEMIOLOGIC ASPECTS OF SCHISTOSOMIASIS-MANSONI
    KATZ, N
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1992, 87 : 1 - 9
  • [40] ANTIEOSINOPHIL SERUM AND KINETICS OF EOSINOPHILIA IN SCHISTOSOMIASIS-MANSONI
    MAHMOUD, AAF
    WARREN, KS
    GRAHAM, RC
    JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 142 (03): : 560 - 574